News | Angiography | September 25, 2018

Osprey Medical and GE Healthcare Launch Acute Kidney Injury Educational Program

Partners will host multiple educational programs on strategies to address AKI following angiograms in patients with chronic kidney disease

Osprey Medical and GE Healthcare Launch Acute Kidney Injury Educational Program

September 21, 2018 — Osprey Medical announced a collaboration with GE Healthcare on Osprey’s Be Kind to Kidneys campaign. The campaign aims to increase awareness of strategies to help address acute kidney injury (AKI) following normal heart imaging procedures (angiograms) in patients with chronic kidney disease (CKD). As part of the campaign, Osprey Medical and GE Healthcare will sponsor a number of educational programs and seminars for healthcare professionals on how to address the risk of AKI.

AKI is sudden damage to the kidneys that causes them to not work properly. It can range from minor loss of kidney function to complete kidney failure.1 With one out of four angiography patients presenting with CKD,2 the risk for these patients to develop AKI is a serious concern for catheterization labs and hospitals. Patients with impaired kidneys are at a significantly increased risk for negative outcomes and for longer hospital stays.3 The American College of Cardiology and American Heart Association have issued joint guidelines for the reduction of AKI.4 These guidelines recommend that physicians should screen patients for risk of AKI, ensure they are properly hydrated, and minimize the volume of contrast dye used. Osprey and GE Healthcare’s campaign intends to reinforce these guidelines and increase awareness so that healthcare professionals can help patients with CKD.

The campaign kicks off in September with a series of two-day educational programs in the United States for nurses and technicians. The programs will focus on strategies to reduce contrast volume using Osprey’s DyeVert Plus system, cleared by the U.S. Food and Drug Administration (FDA) for contrast reduction and real-time monitoring of dye dose to patients throughout the angiogram. The programs will also focus on approaches to help reduce the risk of AKI in patients with poor kidney function undergoing heart imaging procedures.

GE Healthcare's isosmolar imaging agent Visipaque (iodixanol) injection is an intravascular contrast agent that is used to assist in interventional and diagnostic procedures and will also be discussed in the educational programs.

In addition, during the Transcatheter Cardiovascular Therapeutics (TCT) 2018 Annual Meeting, Sept. 21-25 in San Diego, Osprey and GE Healthcare will host a symposium with presentations on “Contrast-Induced Acute Kidney Injury: Preventive Measures Worth Trying and “The Effect of Major Adverse Renal Cardiac Events (MARCE) Incidence and Economic Impact Resulting From Contrast Media Use in the Cath Lab.”

Watch the VIDEO: Strategies to Avoid Acute Kidney Injury Caused by Cath Lab Contrast, an interview with Roxana Mehran, M.D.

For more information: www.ospreymed.com, www.gehealthcare.com

 

References

1. Acute kidney injury. National Health Service Website. https://www.nhs.uk/conditions/acute-kidney-injury/. Accessed Sept. 10, 2018.

2. Tsai T.T., Patel U.D., Change T.I., et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions. JACC. Cardiovasc Inter. 2014;7:1-9.

3. Subramanian S., Tumlin J., Bapat B., Zyczynski T. Economic burden of CIN: implications for prevention strategies. J Med Econ. 2007;10:119-134.

4. Levine G.N., Bates E.R., Blankenship J.C., et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:e574-e651.

Related Content

The Philips Illumio system provides the radiologist with meaningful patient data and is anatomy-aware,  to suggest the right tools based on what the user is looking at.

The Philips Illumio system provides the radiologist with meaningful patient data and is anatomy-aware, to suggest the right tools based on what the user is looking at.

Feature | Enterprise Imaging | March 05, 2021 | By Dave Fornell
Radiology enterprise imaging platforms and...
CT imaging radiation dose tracking software from Imalogix displayed at RSNA 2019.

CT imaging radiation dose tracking software from Imalogix displayed at RSNA 2019. Photo by Dave Fornell.

Feature | Radiation Dose Management | March 04, 2021 | By Dave Fornell
More than a decade ago, there was an alarming, rapid rise in ionizing radiation exposure in the U.S.
GE Healthcare introduced its artificial intelligence (AI) automation features on its Voluson Swift ultrasound platform at the 2020 Radiological Society of North America (RSNA) virtual meeting. Features of this system include semi-automated contouring, auto identification of fetal anatomy and positioning on imaging. AI is seeing increasing integration in ultrasound systems from numerous vendors.

GE Healthcare introduced its artificial intelligence (AI) automation features on its Voluson Swift ultrasound platform at the 2020 Radiological Society of North America (RSNA) virtual meeting. Features of this system include semi-automated contouring, auto identification of fetal anatomy and positioning on imaging. AI is seeing increasing integration in ultrasound systems from numerous vendors.

Feature | Ultrasound Imaging | March 04, 2021 | By Dave Fornell, Editor
Recent advances in ultrasound image sy...
Philips and The Walt Disney Company EMEA announced they are teaming up to test the effects of custom-made animation, including specially-made Disney stories, within Philips Ambient Experience, a solution that integrates architecture, design and enabling technologies, such as dynamic lighting, video projections and sound, to allow patients and staff to personalize their environment to create a relaxing atmosphere

Study will explore the effects and use of animated stories and characters, including Disney favorites, as part of Philips Ambient Experience solution.

News | Magnetic Resonance Imaging (MRI) | March 03, 2021
March 3, 2021 — ...
Researchers said women who skip even one scheduled mammography screening before a breast cancer diagnosis face a significantly higher risk of dying from the cancer.

Getty Images

News | Mammography | March 03, 2021
March 3, 2021 — Attendance at regular ...
Guerbet announced the launch of OptiProtect 3S, a new range of technical services for its injection solutions. OptiProtect 3S is designed to support imaging centers in the daily use and protection of their injection solutions.
News | Contrast Media Injectors | February 25, 2021
February 25, 2021 — Guerbet announced the launch of ...
icobrain cva allows the quantitative assessment of tissue perfusion by reporting the volume of core and perfusion lesion by quantifying Tmax abnormality and CBF abnormality together with the mismatch volume and ratio
News | Artificial Intelligence | February 23, 2021
February 23, 2021 — icometrix, world leader in imaging...
Comparison of breast cancer mortality rates (red squares) and distant-stage breast cancer incidence rates from SEER9 (blue dots) and SEER18 (green dots) per 100,000 for white women aged, A, 20–39, B, 40–69, and, C, 70–79 years (3,7,8).

Comparison of breast cancer mortality rates (red squares) and distant-stage breast cancer incidence rates from SEER9 (blue dots) and SEER18 (green dots) per 100,000 for white women aged, A, 20–39, B, 40–69, and, C, 70–79 years (3,7,8). Image courtesy of Radiology 

News | Breast Imaging | February 10, 2021
February 10, 2021 — Breast cancer death rates have stopped declining for women in the U.S.

Images in 69-year-old man with biopsy-confirmed Gleason score 7 (3+4) prostate cancer. (a) Pretreatment axial T2-weighted fast spin-echo MRI scan (repetition time msec/echo time msec, 3820/97) shows tumor in midline anterior transition zone (arrow). (b) Intraoperative MRI scan shows contoured rectal wall (red line), prostate margin (blue outline), and region of interest (orange outline). Because the urethra was included in planned treatment volume, a suprapubic catheter was placed for continuous bladder drainage during treatment. (c) Intraoperative MRI scan shows focused ultrasound beam path (blue) overlaid on treatment plan. Rectangles illustrate each sonication spot. (d) Thermal map image obtained during treatment with heat deposition color coded in red overlaid on sonication spot. (e) Axial gadopentetate dimeglumine-enhanced MRI scan (230/2.97) obtained immediately after treatment shows devascularized ablated volume (arrows). (f) Corresponding T2-weighted fast spin-echo MRI scan (3820/97) at 5 months after ablation shows complete involution of transition zone. All seven cores from treatment area margins were negative for cancer at biopsy. Image courtesy of the Radiological Society of North America

News | Prostate Cancer | February 05, 2021
February 5, 2021 — A technique that delivers...